We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Neurodegeneration – Products

Ubiquigent Appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board content piece image
Product News

Ubiquigent Appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board

Ubiquigent Limited has announced the expansion of its Scientific Advisory Board with the appointments of Professor Helen Walden and Professor John Davis.
Type I IFNs: First-Line of Defense Against Viral Infections and Neoplastic Transformation content piece image
Product
Advertisement

Type I IFNs: First-Line of Defense Against Viral Infections and Neoplastic Transformation

Sino Biological has developed an array of high-quality Proteins, Antibodies, Genes, Lysate, and qPCR Primer Pairs to support the study of IFN-Is.
Avacta Announces Second Dose Escalation in the Phase I Clinical Study of AVA6000 Pro-Doxorubicin content piece image
Product News

Avacta Announces Second Dose Escalation in the Phase I Clinical Study of AVA6000 Pro-Doxorubicin

Avacta Group plc announces that the first-in-human Phase I trial of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.
Assay Kits, Biomarkers and Antibodies for Investigating Oxidative Stress content piece image
Product News

Assay Kits, Biomarkers and Antibodies for Investigating Oxidative Stress

AMSBIO has expanded its range of antibodies, biomarkers and assay kits related to free radicals, non-radical reactive derivatives and antioxidants for researchers investigating the mechanism of oxidative stress.
Isolation of High Purity Exosomes content piece image
Product News

Isolation of High Purity Exosomes

AMSBIO is a leading supplier of high purity exosomes using isolation methods including traditional differential and gradient ultracentrifugation, immunoaffinity, size exclusion chromatography as well as precipitation / low speed centrifugation.
Therapeutic Targets for Neurodegenerative Diseases content piece image
Product
Advertisement

Therapeutic Targets for Neurodegenerative Diseases

Sino Biological has developed a panel of high-quality recombinant GDNF, NGF, and BDNF to support the research for neurodegenerative diseases.
GDNF: A Neurotrophic and Neuroprotective Factor content piece image
Product
Advertisement

GDNF: A Neurotrophic and Neuroprotective Factor

Glial cell line-derived neurotrophic factor (GDNF) plays a vital role in promoting motor neuron survival and axon outgrowth. It is being evaluated in clinical trials as a potential therapeutic for Parkinson’s disease. GFL-like drugs are also being developed to treat disorders such as neuropathic pain and addiction.
Novel Aggregation-Specific Fluorogen Monitors Prefibrillar Protein Aggregation by Fluorescence Polarization content piece image
App Note / Case Study

Novel Aggregation-Specific Fluorogen Monitors Prefibrillar Protein Aggregation by Fluorescence Polarization

Highly ordered protein aggregates, termed amyloid fibrils, are associated with a broad range of diseases, many of which are neurodegenerative for example Alzheimer’s and Parkinson’s. The transition from soluble, functional protein to insoluble amyloid fibril occurs via a complex process involving the initial generation of highly dynamic early stage aggregates or prefibrillar species.
Custom Biofluid & Tissue Procurement Service content piece image
Product News

Custom Biofluid & Tissue Procurement Service

Global provider of human and animal biospecimens - AMSBIO offers a custom procurement service enabling researchers to source specific biofluid and tissue samples which are not already available in their extensive biorepository.
Ferrer and Treeway Enter Into Licence Agreement for the Development and Commercialisation of TW001/FNP122 for Amyotrophic Lateral Sclerosis content piece image
Product News

Ferrer and Treeway Enter Into Licence Agreement for the Development and Commercialisation of TW001/FNP122 for Amyotrophic Lateral Sclerosis

Ferrer and Treeway have announced they have entered into a license agreement for the development and commercialization of an oral formulation of edaravone for Amyotrophic Lateral Sclerosis.
Advertisement